Vascepa to Accelerate Lipoprotein Uptake and Elimination
Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This study is a Phase 1 pilot/feasibility mechanistic experiment to help clarify the
mechanism of action of an EPA-rich fish oil preparation, icosapent ethyl, on lipid changes in
statin-treated patients with residual triglyceridemia.